207 related articles for article (PubMed ID: 21959954)
1. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.
Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B
Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
Zhang B; Tao F; Zhang H
Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
[TBL] [Abstract][Full Text] [Related]
3. Nickel-induced VEGF expression via regulation of Akt, ERK1/2, NFκB, and AMPK pathways in H460 cells.
Wang JC; Chen SY; Wang M; Ko JL; Wu CL; Chen CC; Lin HW; Chang YY
Environ Toxicol; 2019 May; 34(5):652-658. PubMed ID: 30724446
[TBL] [Abstract][Full Text] [Related]
4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
Wan J; Wu W
J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
[TBL] [Abstract][Full Text] [Related]
6. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
[TBL] [Abstract][Full Text] [Related]
9. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer.
Liu G; Xu S; Jiao F; Ren T; Li Q
Tumour Biol; 2015 Mar; 36(3):2185-91. PubMed ID: 25424698
[TBL] [Abstract][Full Text] [Related]
13. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC).
Mao Z; Xu B; He L; Zhang G
Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971
[TBL] [Abstract][Full Text] [Related]
14. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells.
Kharbanda A; Rajabi H; Jin C; Alam M; Wong KK; Kufe D
Oncotarget; 2014 Oct; 5(19):8893-905. PubMed ID: 25245423
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
16. ILT4 facilitates angiogenesis in non-small cell lung cancer.
Wang S; Wang J; Gong W; Zhang F; Chen X; Xu H; Han Y; Fu X; Wang L; Li J; Gao A; Sun Y
Cancer Sci; 2024 May; 115(5):1459-1475. PubMed ID: 38433526
[TBL] [Abstract][Full Text] [Related]
17. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
Ming J; Liu N; Gu Y; Qiu X; Wang EH
Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Han J; Hu J; Sun F; Bian H; Tang B; Fang X
Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
[TBL] [Abstract][Full Text] [Related]
19. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
